About Index Trending news
Analyze
Pricing
immuneXcite

immuneXcite

immuneXcite

Biopharmaceuticals ImmuneXcite is a biopharmaceutical company focused on developing the next generation of monoclonal antibodies for cancer, employing....

Elsewhere

Contributors to this profile

Alexa global traffic share

Latest funding
Venture capital (Series A)
$8,600,000
Partners Innovation Fund, Cormorant Asset Management, Sanofi-Genzyme BioVentures
Venture capital (Series A)
$8,600,000
Partners Innovation Fund, Cormorant Asset Management, Sanofi-Genzyme BioVentures
Employees

Unknown size

Locations
HQ
Headquarters
$8,600,000 Venture capital (Series A)
FierceBiotech , ImmuneXcite

Sanofi Genzyme helps cancer biotech ImmuneXcite close $8.6M financing round

Health Funding
$8,600,000 Venture capital (Series A)
FinSMEs , Xconomy

ImmuneXcite Completes $8.6M Series A-1 Financing

Health Funding